The Centers for Medicare & Medicaid Services has revised the way Medicare administrative contractors make local coverage determinations for medical technologies, as required by the 21st Century Cures Act to promote transparency. Among other changes, the updated process expands who can participate on the contractor advisory committees that inform LCDs, opens CAC meetings to the public and requires a standardized summary of the clinical evidence supporting an LCD decision. CMS said the changes, published as an update to the Medicare Program Integrity Manual, will clarify and simplify the LCD process so that companies can get therapies and devices to patients more efficiently.

Related News Articles

Perspective
On Tuesday, the Census Bureau reported that “a third of Americans now show signs of clinical anxiety or depression” due to the COVID-19 pandemic. It’s also…
Headline
The Centers for Medicare & Medicaid Services yesterday released a fact sheet for state and local governments seeking Medicare, Medicaid or Children’s…
Headline
Over 1,750 Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs…
Headline
The Government Accountability Office today named three new members to the Medicare Payment Advisory Commission through April 2023. They are: Wayne…
Headline
An annual report into death by several factors tied to mental health and wellbeing — otherwise referred to as “deaths of despair” — topped 150,000 in 2018. The…
Headline
State Medicaid programs are reporting an uptick in enrollment compared with their fiscal year 2020 projections, due in part to the COVID-19 pandemic. The…